These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


60 related items for PubMed ID: 3025418

  • 1. Cardiac and vascular actions of decapeptide angiotensin analogs.
    Baker KM, Khosla MC.
    J Pharmacol Exp Ther; 1986 Dec; 239(3):790-6. PubMed ID: 3025418
    [Abstract] [Full Text] [Related]

  • 2. Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study.
    Waldeck K, Lindberg BF, Persson K, Andersson KE.
    Br J Pharmacol; 1997 Jul; 121(6):1081-6. PubMed ID: 9249242
    [Abstract] [Full Text] [Related]

  • 3. Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta.
    Saye JA, Singer HA, Peach MJ.
    Hypertension; 1984 Jul; 6(2 Pt 1):216-21. PubMed ID: 6202632
    [Abstract] [Full Text] [Related]

  • 4. Inotropic cardiac and vascular actions of [Ala7]angiotensin analogs.
    Trachte GJ, Ackerly JA, Peach MJ.
    J Cardiovasc Pharmacol; 1981 Jul; 3(4):838-46. PubMed ID: 6167813
    [Abstract] [Full Text] [Related]

  • 5. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM, Kemp PA, Brunner-Ferber F, Bennett T.
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [Abstract] [Full Text] [Related]

  • 6. A cardiac specific analog of angiotensin I potentiated by converting enzyme inhibition.
    Cross RB, Dallemagne C, Beswick E, Khosla MC, Bumpus FM.
    Life Sci; 1985 Feb 18; 36(7):613-8. PubMed ID: 2982072
    [Abstract] [Full Text] [Related]

  • 7. Effects of locally generated angiotensin II on noradrenergic transmission in guinea-pig isolated atria.
    Ziogas J, Story DF, Rand MJ.
    Eur J Pharmacol; 1984 Oct 30; 106(1):11-8. PubMed ID: 6099265
    [Abstract] [Full Text] [Related]

  • 8. Drugs inhibiting the renin - angiotensin system.
    Antonaccio MJ, Cushman DW.
    Fed Proc; 1981 Jun 30; 40(8):2275-84. PubMed ID: 6263716
    [Abstract] [Full Text] [Related]

  • 9. Identification of macrophage receptors for angiotensin: a potential role in antigen uptake for T lymphocyte responses?
    Thomas DW, Hoffman MD.
    J Immunol; 1984 Jun 30; 132(6):2807-12. PubMed ID: 6327810
    [Abstract] [Full Text] [Related]

  • 10. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
    le Tran Y, Forster C.
    Can J Physiol Pharmacol; 1996 Dec 30; 74(12):1277-86. PubMed ID: 9047036
    [Abstract] [Full Text] [Related]

  • 11. Modulation of angiotensin-converting enzyme by nitric oxide.
    Ackermann A, Fernández-Alfonso MS, Sánchez de Rojas R, Ortega T, Paul M, González C.
    Br J Pharmacol; 1998 May 30; 124(2):291-8. PubMed ID: 9641545
    [Abstract] [Full Text] [Related]

  • 12. Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility.
    Trongtorsak P, Morgan TO, Delbridge LM.
    J Renin Angiotensin Aldosterone Syst; 2003 Dec 30; 4(4):213-9. PubMed ID: 14689368
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
    Nickenig G, Laufs U, Schnabel P, Knorr A, Paul M, Böhm MP.
    Br J Pharmacol; 1997 May 30; 121(1):134-40. PubMed ID: 9146897
    [Abstract] [Full Text] [Related]

  • 14. Hepatic conversion of angiotensin I and the portal hypertensive response to angiotensin II in normal and regenerating liver.
    Carvalho LT, Nascimento EA, Teixeira FO, Nagaoka MR, Borges DR, Kouyoumdjian M.
    J Gastroenterol Hepatol; 2007 Sep 30; 22(9):1543-8. PubMed ID: 17683495
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II receptor subtypes in bovine and human ventricular myocardium.
    Nozawa Y, Haruno A, Oda N, Yamasaki Y, Matsuura N, Yamada S, Inabe K, Kimura R, Suzuki H, Hoshino T.
    J Pharmacol Exp Ther; 1994 Aug 30; 270(2):566-71. PubMed ID: 8071849
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of angiotensin I converting enzyme inhibition by SQ20,881 (less than Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo. Further evidence for extrapulmonary conversion.
    Oparil S, Koerner T, O'Donoghue JK.
    Hypertension; 1979 Aug 30; 1(1):13-22. PubMed ID: 232489
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin analogues that selectively augment the force of contraction of the isolated heart.
    Khosla MC, Bachynsky E, Forgac S, Lakios-Cherpas C, Bumpus FM.
    Hypertension; 1988 Feb 30; 11(2 Pt 2):I38-41. PubMed ID: 3346064
    [Abstract] [Full Text] [Related]

  • 18. Effect of angiotensins on electrogenic anion transport in monolayer cultures of rat epididymis.
    Wong PY, Fu WO, Huang SJ, Law WK.
    J Endocrinol; 1990 Jun 30; 125(3):449-56. PubMed ID: 2165124
    [Abstract] [Full Text] [Related]

  • 19. An in vitro system for study of effects of angiotensin I on cultured endothelial cells.
    Bagby SP, Holden WE.
    Cardiovasc Res; 1989 Apr 30; 23(4):279-85. PubMed ID: 2556215
    [Abstract] [Full Text] [Related]

  • 20. Cardiac production of angiotensin II and its pharmacologic inhibition: effects on the coronary circulation.
    Schmermund A, Lerman LO, Ritman EL, Rumberger JA.
    Mayo Clin Proc; 1999 May 30; 74(5):503-13. PubMed ID: 10319084
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.